Nom du produit:6-Hydroxy-N,2-dimethylbenzofuran-3-carboxamide
IUPAC Name:6-hydroxy-N,2-dimethyl-1-benzofuran-3-carboxamide
- CAS：638217-08-0
- Formule moléculaire：C11H11NO3
- Pureté：97%
- Numéro de catalogue：CM160779
- Poids moléculaire：205.21
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:638217-08-0
- Formule moléculaire:C11H11NO3
- Point de fusion:-
- Code SMILES:CNC(=O)C1=C(C)OC2=C1C=CC(O)=C2
- Densité:
- Numéro de catalogue:CM160779
- Poids moléculaire:205.21
- Point d'ébullition:259.1°C at 760 mmHg
- N° Mdl:MFCD09836137
- Stockage:Store at 2-8°C.
Category Infos
- Benzofurans
- Benzofuran is an aromatic heterocyclic organic compound with the chemical formula C8H6O. It is a colorless oily liquid at room temperature with an aromatic odor. Benzofuran can be volatilized with water vapor and can be decomposed by potassium permanganate and other oxidants. It is an intermediate for the preparation of amiodarone and indene resin. Benzofuran derivatives are important pharmaceutical intermediates.
- Benzofuran | C8H6O | CID 9223 -Chemenu
- Benzofuran | C8H6O | CID 9223 |Where to Buy Benzofurans
- Benzofuran is the heterocyclic compound consisting of fused benzene and furan rings. This colourless liquid is a component of coal tar.Benzofuran is extracted from coal tar. It is also obtained by dehydrogenation of 2-ethylphenol.
Column Infos
- Fruquintinib
- November 08, 2023, FDA has approved FRUZAQLA(fruquintinib), an oral targeted therapy for adults with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.
FRUZAQLA is the first and only selective inhibitor of all three VEGF receptor kinases approved in the U.S. for previously treated mCRC regardless of biomarker status.
Recherche 
+86 21 5895 0110 
